Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial

Clinical trial NCT01799486 · UNKNOWN

Trial details

NCT number: NCT01799486
Sponsor: Lin Bingliang
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

HBV-related Liver Cirrhosis

Start date: 2013-02-01
Primary completion: 2013-02-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.